AbCheck s.r.o.
Claudia Wurzenberger is currently the VP of Project Management at AbCheck s.r.o. Previously, Claudia worked as a Project Lead Discovery at Pieris Pharmaceuticals, Sr. Scientist at Immunocore Limited, and a Postdoctoral Research Associate at the University of Cambridge. Claudia holds a PhD in Cell/Cellular and Molecular Biology from ETH Zürich and a Master's degree in Biochemistry from the Technical University of Munich.
This person is not in any teams
This person is not in any offices
AbCheck s.r.o.
AbCheck discovers and optimizes human therapeutic antibodies with one of the industry’s most versatile technology platforms. Tailored to specific needs and desired Target Product Profiles, AbCheck leverages both cutting-edge (e.g., microfluidics, rabbit mass humanization) and state-of-the-art (e.g., phage/yeast display libraries) technologies to provide high quality leads. The company has proven its capabilities in multiple partnerships throughout the U.S. and Europe. AbCheck is a wholly-owned subsidiary of Ampersand Biomedicines, a Flagship Pioneering Company.